insights_auto
Why is NXTCL down ६.७५%?
Dive Deeperchevron_right
NXTCL:STO
NextCell Pharma AB
SEK ०.२३
arrow_downward
-६.७५%(-०.०१६) 1D
नोभेम्बर १८, १७:२१:५४ GMT+१ · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NXTCL...
Open
SEK ०.२३
High
SEK ०.२५
Low
SEK ०.२२
Mkt. cap
२.९४ करोड
Avg. vol.
१०.०९ लाख
Volume
८८.८२ हजार
52-wk high
SEK १.७८
52-wk low
SEK ०.२०
EPS
-SEK ०.४५
Shares outstanding
११.१४ करोड
No. of employees
२१
Open
SEK ०.२३
High
SEK ०.२५
Low
SEK ०.२२
Mkt. cap
२.९४ करोड
Avg. vol.
१०.०९ लाख
Volume
८८.८२ हजार
52-wk high
SEK १.७८
52-wk low
SEK ०.२०
EPS
-SEK ०.४५
Shares outstanding
११.१४ करोड
No. of employees
२१
News stories
From web sources and news partners
BigGo Finance
·
४७ मिनेट पहिले
UBS Sets S&P 500 Target of 8,200 by End-2027, Implying Roughly 12% Upside, But Cuts Rating to Neutral
FOREX.com
·
७ मिनेट पहिले
S&P 500 Grasps At Support as Surging Hike Odds, Treasury Yields Threaten Larger Turn
Stocktwits
·
१ घण्टा पहिले
Nasdaq, Dow, S&P 500 Futures Climb Ahead Of Anthropic’s Record Debut: SLS, GLD, TTWO, UNH In Focus
Traders Union
·
३ घण्टा पहिले
S&P 500 dips below 200-day average after long streak, Ryan Detrick notes
Profile
NextCell Pharma AB is a Swedish biopharmaceutical company headquartered in Huddinge, in the Flemingsberg life-science cluster south of Stockholm. The company develops allogeneic mesenchymal stromal cell therapies, with its lead candidate aimed at preserving insulin production in newly diagnosed type 1 diabetes. Alongside its drug development programme, NextCell operates a private umbilical cord stem cell bank and a contract manufacturing and analytical services subsidiary for Advanced Therapy Medicinal Products. NextCell's shares trade on the Nasdaq First North Growth Market in Stockholm under the ticker NXTCL. Wikipedia
About NextCell Pharma AB
CEOMathias Svahn
Employees२१
Founded२०१४ मार्च १९
Headquarters-
SectorHealth Care
Industry-
Websitenextcellpharma.com